Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Raghuram Selvaraju downgrades MoonLake (NASDAQ:MLTX) from Buy to Neutral.
Guggenheim analyst Yatin Suneja maintains MoonLake (NASDAQ:MLTX) with a Buy and lowers the price target from $80 to $20.
Wedbush analyst Yun Zhong maintains MoonLake (NASDAQ:MLTX) with a Outperform and lowers the price target from $80 to $18.
Citigroup analyst Samantha Semenkow downgrades MoonLake (NASDAQ:MLTX) from Buy to Neutral and lowers the price target from $...
Needham analyst Serge Belanger maintains MoonLake (NASDAQ:MLTX) with a Buy and lowers the price target from $66 to $20.
U.S. stocks advanced today, with the Nasdaq climbing about 107 points, or 0.48%, to 22,591.15. The S&P 500 added 0.26% to c...
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Monday. The Dow traded do...
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...
